Previous 10 | Next 10 |
home / stock / emhtf / emhtf news
Emerald Health Therapeutics (EMHTF) is an interesting cannabis stock due to its 50% ownership interest in Pure Sunfarms, a cannabis operation that has brought immense fortune to the other JV partner, Village Farms (VFF). We will discuss Emerald's recent execution and why we think the market i...
Cannabis stocks haven't been doing well this year, and that's created some great buying opportunities. And none might be better than Village Farms International (NASDAQ: VFF) . While it has only dropped around 6% in the past three months, at a market cap of a little over $500 millio...
The cannabis sector is widely projected to be one of the market's fastest-growing areas over the next decade, if not longer. The nascent Canadian recreational market should continue to boost that country's overall marijuana sales, more countries will likely eventually fully legalize cannabis, an...
VANCOUVER, British Columbia, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), a Canadian licenced producer of medicinal and recreational cannabis products, and HelloMD, a leading online cannabis healthcare company, hav...
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. ("Emerald" or the "Company") (TSXV: EMH; OTCQX: EMHTF) announces that it has closed its pr...
VANCOUVER, British Columbia, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announced that its 50%-owned joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has received from Heal...
The FDA approves privately held Boehringer Ingelheim's Ofev (nintedanib) to slow the rate of decline in pulmonary function in adult patients with interstitial lung disease associated with systemic sclerosis , a rare disorder of unknown cause characterized by diffuse scarring and va...
For more than a decade, Apple (NASDAQ: AAPL) has been considered a leader in innovation. The company's iPhone is practically a staple in the U.S., with growth in Apple's wearables, digital music service, and streaming content really beginning to pick up steam . Apple's consistent profitabil...
VANCOUVER, British Columbia, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announced that its 50%-owned joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms (PSF), has entered into...
Welcome to our Cannabis Earnings series where we break down the latest earnings to help you focus on the most important topics. Introduction Emerald Health Therapeutics ( OTCQX:EMHTF ) only had $3 million cash left at the end of Q2. The company managed to get $25 million from issuing ...
News, Short Squeeze, Breakout and More Instantly...
Emerald Health Therapeutics Company Name:
EMHTF Stock Symbol:
OTCMKTS Market:
Emerald Health Therapeutics Website:
Emerald Health Therapeutics Inc (EMHTF) is expected to report for Q3 2022
Vancouver, British Columbia--(Newsfile Corp. - November 10, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") announced today that its Plan of Arrangement with Skye Bioscience, Inc. ("Skye") has closed and that it has entered into agreements to di...
Skye will continue to pursue Canadian Securities Exchange listing following closing of transaction Vancouver, British Columbia--(Newsfile Corp. - November 7, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") and Skye Bioscience, Inc. (OTCQB: SKYE...